Cited by 341Statistical Methods in Clinical TrialsProbability and Statistical ResearchStatistical Methods and Bayesian Inference

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Approximately Optimal One-Parameter Boundaries for Group Sequential Trials

Wang, Samuel K., Tsiatis, Anastasios A.·1987·Biometrics

DOI 10.2307/2531959

Open this paper in CoChat — free account

Abstract

We present a class of group sequential tests, indexed by a single parameter, that yields approximately optimal results. We also provide tables of key values to help in the design of group sequential tests that meet selected specifications.

Integrity signals

Registry

Crossref · 10.2307/2531959

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Group sequential methods in the design and analysis of clinical trials
POCOCK, S. J. (1977) · Biometrika · doi:10.1093/biomet/64.2.191 · Cited by 1,831
Repeated Significance Tests on Accumulating Data
Armitage, P., McPherson, C. K., & Rowe, B. C. (1969) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2343787 · Cited by 772
Interim Analyses for Randomized Clinical Trials: The Group Sequential Approach
Pocock, S. (1982) · Biometrics · doi:10.2307/2530298 · Cited by 265

Flagged first, then by citations

Show all 4 references

Sorted by citations

Items 101–200 of 340

The U.S. Food and Drug Administration's Mini‐Sentinel Program
Platt, R. G., & Carnahan, R. M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3230 · Cited by 27
Adaptive clinical trial designs with pre‐specified rules for modifying the sample size: understanding efficient types of adaptation
Levin, G. P., Emerson, S. C., & Emerson, S. S. (2012) · Statistics in Medicine · doi:10.1002/sim.5662 · Cited by 27
Adaptive design implementation in confirmatory trials: methods, practical considerations and case studies
Li, Q., Lin, J., & Lin, Y. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106096 · Cited by 25
Predicted Interval Plots (PIPS): A Graphical Tool for Data Monitoring of Clinical Trials
Li, L., Evans, S. R., Uno, H., & Wei, L. J. (2009) · Statistics in Biopharmaceutical Research · doi:10.1198/sbr.2009.0041 · Cited by 25
Methods for observational post-licensure medical product safety surveillance
Nelson, J. C., Cook, A. J., Yu, O., Zhao, S., Jackson, L. A., & Psaty, B. M. (2011) · Statistical Methods in Medical Research · doi:10.1177/0962280211413452 · Cited by 24
Sequential Testing for Early Stopping of Online Experiments
Kharitonov, E., Vorobev, A., Macdonald, C., Serdyukov, P., & Ounis, I. (2015) · International ACM SIGIR Conference on Research and Development in Information Retrieval (SIGIR) · doi:10.1145/2766462.2767729 · Cited by 24
Clinical Efficacy and Safety of Liquid Pelargonium sidoides Preparation (EPs 7630) in Children with Acute Non-Streptococcal Tonsillopharyngitis
Бережной, В. В., Heger, M., Lehmacher, W., & Seifert, G. (2016) · Journal of Comprehensive Pediatrics · doi:10.17795/compreped-42158 · Cited by 23
Statistical Packages for Group Sequential Methods
Emerson, S. S. (1996) · The American Statistician · doi:10.1080/00031305.1996.10474375 · Cited by 23
Optimization of Multistage Testing Times and Critical Values in Clinical Trials
Brittain, E., & Bailey, K. R. (1993) · Biometrics · doi:10.2307/2532197 · Cited by 22
Exploring the benefits of adaptive sequential designs in time‐to‐event endpoint settings
Emerson, S. C., Rudser, K. D., & Emerson, S. S. (2010) · Statistics in Medicine · doi:10.1002/sim.4156 · Cited by 20
Adaptive Group Sequential Test for Clinical Trials with Changing Patient Population
Feng, H., Shao, J., & Chow, S. (2007) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400701645512 · Cited by 20
Group sequential tests for delayed responses
Hampson, L. V. (2008) · Lancaster EPrints (Lancaster University) · Cited by 19
On Sample Size Determination in Multi-Armed Confirmatory Adaptive Designs
Wassmer, G. (2011) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2011.551336 · Cited by 18
A Simple Algorithm for Designing Group Sequential Clinical Trials
Schoenfeld, D. (2001) · Biometrics · doi:10.1111/j.0006-341x.2001.00972.x · Cited by 18
Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint
Li, X., Herrmann, C., & Rauch, G. (2020) · BMC Medical Research Methodology · doi:10.1186/s12874-020-01141-5 · Cited by 17
A Practical Guide to Data Monitoring Committees in Adaptive Trials
Sanchez‐Kam, M., Gallo, P. P., Loewy, J. W., Menon, S., Antonijevic, Z., Christensen, J., Chuang‐Stein, C., & Laage, T. A. (2013) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479013509805 · Cited by 17
Comparison of the Two-Sided Single Triangular Test to the Double Triangular Test
Sebille, V., & Bellissant, É. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00154-4 · Cited by 17
Opiate sparing effect of fixed combination of diclophenac and orphenadrine after unilateral total hip arthroplasty: A double-blind, randomized, placebo-controlled, multi-centre clinical trial
Gombotz, H., Lochner, R., Sigl, R., Blasl, J., Herzer, G., & Trimmel, H. (2010) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-010-0829-7 · Cited by 16
Optimal designs for group sequential clinical trials
Chang, M. N. (1996) · Communication in Statistics- Theory and Methods · doi:10.1080/03610929608831700 · Cited by 16
Asymptotically optimal multistage tests of simple hypotheses
Bartroff, J. L. (2007) · The Annals of Statistics · doi:10.1214/009053607000000235 · Cited by 16
Group sequential designs for three‐arm ‘gold standard’ non‐inferiority trials with fixed margin
Schloemer, P., & Brannath, W. (2013) · Statistics in Medicine · doi:10.1002/sim.5950 · Cited by 16
Investigating the effect of intra-operative infiltration with local anaesthesia on the development of chronic postoperative pain after inguinal hernia repair. A randomized placebo controlled triple blinded and group sequential study design [NCT00484731]
Honigmann, P., Fischer, H., Kurmann, A. A., Audigé, L., Schüpfer, G., & Metzger, J. (2007) · BMC Surgery · doi:10.1186/1471-2482-7-22 · Cited by 16
Pre-Registered Interim Analysis Designs (PRIADs): Increasing the Cost-Effectiveness of Hypothesis Testing
André, Q., & Reinholtz, N. (2024) · Journal of Consumer Research · doi:10.1093/jcr/ucae028 · Cited by 16
A flexible futility monitoring method with time-varying conditional power boundary
Zhang, Y., & Clarke, W. R. (2010) · Clinical Trials · doi:10.1177/1740774510369686 · Cited by 15
Adaptive Design Methods in Clinical Trials
Pong, A. (2012) · CRC Press eBooks · doi:10.1201/b14674-4 · Cited by 15
Multidisciplinary rehabilitation program in recently hospitalized patients with heart failure and preserved ejection fraction: Rationale and design of a randomized controlled trial
Koifman, E., Grossman, E., Elis, A., Dicker, D., Koifman, B., Mosseri, M., Kuperstein, R., Goldenberg, I., Kamerman, T., Levine-Tiefenbrun, N., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.08.010 · Cited by 14
Group sequential t-test for clinical trials with small sample sizes across stages
Shao, J., & Feng, H. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2007.02.006 · Cited by 14
Sequential Monitoring of Covariate-Adaptive Randomized Clinical Trials
Hu, F., & Hu, H. (2017) · Statistica Sinica · doi:10.5705/ss.202016.0330 · Cited by 14
Nested combination tests with a time‐to‐event endpoint using a short‐term endpoint for design adaptations
Jörgens, S., Wassmer, G., König, F., & Posch, M. (2019) · Pharmaceutical Statistics · doi:10.1002/pst.1926 · Cited by 14
The double triangular test in practice
Whitehead, J., & Todd, S. (2004) · Pharmaceutical Statistics · doi:10.1002/pst.91 · Cited by 14
On the Use of Stochastic Curtailment in Group Sequential Clinical Trials
Emerson, S. S., Kittelson, J. M., & Gillen, D. L. (2005) · Collection of Biostatistics Research Archive · Cited by 14
On group sequential tests for data in unequally sized groups and with unknown variance
Jennison, C., & Turnbull, B. W. (2001) · Journal of Statistical Planning and Inference · doi:10.1016/s0378-3758(00)00339-6 · Cited by 14
Exact sequential test for clinical trials and post‐market drug and vaccine safety surveillance with Poisson and binary data
Silva, I. R., Maro, J. C., & Kulldorff, M. (2021) · Statistics in Medicine · doi:10.1002/sim.9094 · Cited by 13
Strategies for Including Patients Recruited During Interim Analysis of Clinical Trials
Faldum, A., & Hommel, G. (2007) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400701645439 · Cited by 13
BOP2-TE: Bayesian optimal phase 2 design for jointly monitoring efficacy and toxicity with application to dose optimization
Chen, K., Zhou, H., Lee, J. J., & Yuan, Y. (2024) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2024.2429481 · Cited by 11
Group Sequential Method for Observational Data by Using Generalized Estimating Equations: Application to Vaccine Safety Datalink
Cook, A. J., Wellman, R., Nelson, J. C., Jackson, L. A., & Tiwari, R. C. (2014) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/rssc.12076 · Cited by 11
A Synthesis of Current Surveillance Planning Methods for the Sequential Monitoring of Drug and Vaccine Adverse Effects Using Electronic Health Care Data
Nelson, J. C., Wellman, R., Yu, O., Cook, A. J., Maro, J. C., Ouellet‐Hellstrom, R., Boudreau, D. M., Floyd, J. S., Heckbert, S. R., Pinheiro, S. P., et al. (2016) · eGEMs (Generating Evidence & Methods to improve patient outcomes) · doi:10.13063/2327-9214.1219 · Cited by 11
Overrunning in clinical trials: some thoughts from a methodological review
Baldi, I., Azzolina, D., Soriani, N., Barbetta, B., Vaghi, P., Giacovelli, G., Berchialla, P., & Gregori, D. (2020) · Trials · doi:10.1186/s13063-020-04526-5 · Cited by 12
An evaluation of inferential procedures for adaptive clinical trial designs with pre‐specified rules for modifying the sample size
Levin, G. P., Emerson, S. C., & Emerson, S. S. (2014) · Biometrics · doi:10.1111/biom.12168 · Cited by 11
S+SeqTrial: Technical Overview
Emerson, S. S. (2007) · Cited by 11
Group Sequential Study Designs in Genetic-Epidemiological Case-Control Studies
König, I. R., & Ziegler, A. (2003) · Human Heredity · doi:10.1159/000073734 · Cited by 11
Study duration for group sequential clinical trials with censored survival data adjusting for stratification
Kim, K. (1992) · Statistics in Medicine · doi:10.1002/sim.4780111106 · Cited by 11
Statistical rules for safety monitoring in clinical trials
Martens, M. J., & Logan, B. R. (2024) · Clinical Trials · doi:10.1177/17407745231203391 · Cited by 10
Regulatory Perspectives on Multiplicity in Adaptive Design Clinical Trials throughout a Drug Development Program
Wang, S., Hung, H., & O’Neill, R. T. (2011) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2011.552878 · Cited by 10
Self-citation
Adaptive designs with arbitrary dependence structure
Schmidt, R., Faldum, A., Witt, O., & Gerß, J. (2013) · Biometrical Journal · doi:10.1002/bimj.201200234 · Cited by 10
Asymmetric Group Sequential Designs under Fractional Brownian Motion
Zhang, Q. (2013) · Communication in Statistics- Theory and Methods · doi:10.1080/03610926.2011.606487 · Cited by 10
Implementing type I & type II error spending for two-sided group sequential designs
Rudser, K. D., & Emerson, S. S. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2007.09.002 · Cited by 10
On the efficiency of adaptive sample size design
Cui, L., & Zhang, L. (2018) · Statistics in Medicine · doi:10.1002/sim.8034 · Cited by 10
Pylorus resection versus pylorus preservation in pancreatoduodenectomy (PyloResPres): study protocol and statistical analysis plan for a German multicentre, single-blind, surgical, registry-based randomised controlled trial
Renz, B. W., Adrion, C., Klinger, C., Ilmer, M., D’Haese, J. G., Buhr, H.-J., Mansmann, U., Werner, J., & PyloResPres study group (2021) · BMJ Open · doi:10.1136/bmjopen-2021-056191 · Cited by 10
A comparison of group sequential and fixed sample size designs for bioequivalence trials with highly variable drugs
Knahl, S. I. E., Lang, B. J., Fleischer, F., & Kieser, M. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2415-7 · Cited by 10
Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs
Wassmer, G. (2003) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-120024196 · Cited by 10
Construction of group sequential designs in clinical trials on the basis of detectable treatment differences
Schäfer, H., & Müller, H. (2004) · Statistics in Medicine · doi:10.1002/sim.1751 · Cited by 10
Optimal flexible sample size design with robust power
Zhang, L., Cui, L., & Yang, B. (2016) · Statistics in Medicine · doi:10.1002/sim.6931 · Cited by 9
Continuous sequential boundaries for vaccine safety surveillance
Li, R., Stewart, B., Weintraub, E., & McNeil, M. M. (2014) · Statistics in Medicine · doi:10.1002/sim.6161 · Cited by 9
Alternative Derivations of a Rule for Early Stopping in Favor ofH0
Betensky, R. A. (2000) · The American Statistician · doi:10.1080/00031305.2000.10474505 · Cited by 9
Group sequential design for time-to-event data using the concept of proportional time
Phadnis, M. A., & Mayo, M. S. (2019) · Statistical Methods in Medical Research · doi:10.1177/0962280219876313 · Cited by 9
Two‐Stage Group Sequential Robust Tests in Family‐Based Association Studies: Controlling Type I Error
Yan, L. K., Zheng, G., & Li, Z. (2008) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2008.00435.x · Cited by 9
Estimation following group-sequential response-adaptive clinical trials
Morgan, C. C. (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00062-x · Cited by 9
Interim monitoring in sequential multiple assignment randomized trials
Wu, L., Wang, J., & Wahed, A. S. (2021) · Biometrics · doi:10.1111/biom.13562 · Cited by 8
Using web-based, guided self-help to bridge the waiting time for face-to-face out-patient treatment for bulimic-spectrum disorders: randomised controlled trial
Vollert, B., Yim, S. H., Görlich, D., Beintner, I., Gordon, G., Musiat, P., Schmidt, U. H., & Jacobi, C. (2024) · BJPsych Open · doi:10.1192/bjo.2023.629 · Cited by 10
More Efficient Ways of Assessing Treatments for Neglected Tropical Diseases Are Required: Innovative Study Designs, New Endpoints, and Markers of Effects
Olliaro, P., Vaillant, M., Sundar, S., & Balasegaram, M. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001545 · Cited by 8
A Procedure for Group Sequential Comparative Poisson Trials
Xia, Q., & Hoover, D. R. (2007) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400701514015 · Cited by 8
Combining an Internal Pilot with an Interim Analysis for Single Degree of Freedom Tests
Kairalla, J. A., Muller, K. E., & Coffey, C. S. (2010) · Communication in Statistics- Theory and Methods · doi:10.1080/03610920903353709 · Cited by 8
Dynamic incorporation of real world evidence within the framework of adaptive design
Lin, J., Liao, R., & Gamalo, M. (2022) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2022.2089159 · Cited by 6
p-Value calculation for multi-stage additive tests
Sheng, J., & Qiu, P. (2007) · Journal of Statistical Computation and Simulation · doi:10.1080/10629360600872707 · Cited by 7
Robustness of an Odds‐ratio Test in a Stratified Group Sequential Trial with a Binary Outcome Measure
Srivastava, D. K., Rai, S. N., & Pan, J. (2006) · Biometrical Journal · doi:10.1002/bimj.200610265 · Cited by 7
Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination
Budd, A. C., & Sturrock, C. J. (2010) · Sexual Health · doi:10.1071/sh09133 · Cited by 7
Some design considerations incorporating early futility for single‐arm clinical trials with time‐to‐event primary endpoints using Weibull distribution
Waleed, M., He, J., & Phadnis, M. A. (2021) · Pharmaceutical Statistics · doi:10.1002/pst.2097 · Cited by 6
Asymptotically Optimal Multistage Tests for Non-iid Data
Xing, Y., & Fellouris, G. (2023) · Statistica Sinica · doi:10.5705/ss.202022.0235 · Cited by 6
Point estimation, confidence intervals, and P‐values for optimal adaptive two‐stage designs with normal endpoints
Meis, J., Pilz, M., Bokelmann, B., Herrmann, C., Rauch, G., & Kieser, M. (2024) · Statistics in Medicine · doi:10.1002/sim.10020 · Cited by 6
Adaptive Design - Recent Advancement in Clinical Trials
Chang, M. (2016) · Journal of Bioanalysis & Biostatistics · doi:10.13188/2641-8681.1000003 · Cited by 6
Statistical Methods Used in Interim Monitoring
Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015) · Springer eBooks · doi:10.1007/978-3-319-18539-2_17 · Cited by 6
Monitoring Response Variables
Friedman, L. M., Furberg, C. D., & DeMets, D. L. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1586-3_16 · Cited by 6
Optimized multiple testing procedures for nested sub-populations based on a continuous biomarker
Graf, A. C., Magirr, D., Dmitrienko, A. A., & Posch, M. (2020) · Statistical Methods in Medical Research · doi:10.1177/0962280220913071 · Cited by 5
4. Sequential Methods for Biomedical Applications
Kim, K., Tsiatis, A. A., & Mehta, C. R. (2003) · Journal of the Japanese Society of Computational Statistics · doi:10.5183/jjscs1988.15.2_153 · Cited by 5
Self-citation
Implementing online interventions in ICare: A biostatistical perspective
Görlich, D., & Faldum, A. (2019) · Internet Interventions · doi:10.1016/j.invent.2018.12.004 · Cited by 5
An additive boundary for group sequential designs with connection to conditional error
Xi, D., & Gallo, P. P. (2019) · Statistics in Medicine · doi:10.1002/sim.8325 · Cited by 5
Refined critical boundary with enhanced statistical power for non-directional two-sided tests in group sequential designs with multiple endpoints
Zhang, F., & Gou, J. (2019) · Statistical Papers · doi:10.1007/s00362-019-01134-7 · Cited by 5
16 Sequential and Group Sequential Designs in Clinical Trials: Guidelines for Practitioners
Mazumdar, M., & Bang, H. (2007) · Handbook of statistics · doi:10.1016/s0169-7161(07)27016-6 · Cited by 5
Weighted Logrank Statistics in Sequential Tests
Gombay, E. (2008) · Sequential Analysis · doi:10.1080/07474940701802059 · Cited by 5
A Note on repeated p-values for group sequential designs
Posch, M., Wassmer, G., & Brannath, W. (2007) · Biometrika · doi:10.1093/biomet/asm080 · Cited by 5
Choice of alpha spending function and time points in clinical trials with one or two interim analyses
Selwyn, M. R., & Fish, S. M. (2004) · Pharmaceutical Statistics · doi:10.1002/pst.108 · Cited by 5
Group sequential designs applied in psychological research
Weigl, K., & Ponocny, I. (2020) · Methodology · doi:10.5964/meth.2811 · Cited by 4
Accounting for variation in the required sample size in the design of group-sequential trials
Grayling, M. J., & Mander, A. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106459 · Cited by 4
Sequential nonparametrics and semiparametrics: Theory, implementation and applications to clinical trials
Lai, T. L., & Su, Z. (2008) · Institute of Mathematical Statistics eBooks · doi:10.1214/193940307000000257 · Cited by 4
Planning sequential clinical trials: A review
Salvan, A. (1990) · Computational Statistics & Data Analysis · doi:10.1016/0167-9473(90)90070-x · Cited by 4
CONDITIONAL PROBABILITY OF SIGNIFICANCE FOR EARLY STOPPING IN FAVOR OF H 0
Wang, Y., & Leung, D. H. Y. (2002) · Sequential Analysis · doi:10.1081/sqa-120014361 · Cited by 4
Group Sequential Analysis Using the New SEQDESIGN and SEQTEST Procedures
Yuan, Y. (2009) · Cited by 3
Overview of Adaptive Design Methods in Clinical Trials
Pong, A., & Chow, S. (2010) · CRC Press eBooks · doi:10.1201/b10279-2 · Cited by 3
Computation of optimal group sequential designs
An, Q., & Chang, M. N. (2016) · Sequential Analysis · doi:10.1080/07474946.2016.1238256 · Cited by 3
Defining information fractions in group sequential clinical trials with multiple endpoints
Xu, T., Qin, Q., & Wang, X. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.03.005 · Cited by 3
A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity
Thall, P. F., Nguyen, H. Q., Wang, X., & Wolff, J. E. A. (2011) · Journal of Statistical Planning and Inference · doi:10.1016/j.jspi.2011.10.016 · Cited by 3
Designing, Monitoring, and Analyzing Group Sequential Clinical Trials Using the RCTdesign Package for R
Gillen, D. L., & Emerson, S. S. (2012) · Lecture notes in statistics · doi:10.1007/978-1-4614-5245-4_11 · Cited by 3
Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning
Burkhardt, B., Faldum, A., & Schmidt, R. (2015) · Methods of Information in Medicine · doi:10.3414/me14-02-0023 · Cited by 3
Sample size increase during a survival trial when interim results are promising
Liu, Y., & Lim, P. (2016) · Communication in Statistics- Theory and Methods · doi:10.1080/03610926.2015.1137596 · Cited by 3
Early Stopping of Cancer Clinical Trials
Dignam, J. J., Bryant, J., & Wieand, H. S. (2005) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420027761-21 · Cited by 3
Smoothing Corrections for Improving Sample Size Recalculation Rules in Adaptive Group Sequential Study Designs
Herrmann, C., & Rauch, G. (2021) · Methods of Information in Medicine · doi:10.1055/s-0040-1721727 · Cited by 3
Group Sequential Designs
Wassmer, G. (2005) · Encyclopedia of Statistical Sciences · doi:10.1002/0471667196.ess7175 · Cited by 3
Sequential monitoring of time-to-event safety endpoints in clinical trials
Martens, M. J., Lian, Q., Geller, N. L., Leifer, E., & Logan, B. R. (2024) · Clinical Trials · doi:10.1177/17407745241304119 · Cited by 2
Group sequential design using restricted mean survival time as the primary endpoint in clinical trials
Li, Z., Geng, X., Hou, Y., & Chen, Z. (2025) · Statistical Methods in Medical Research · doi:10.1177/09622802241304111 · Cited by 2

Authors: Wang, S. K., & Tsiatis, A. A.
Venue: Biometrics
Publisher: JSTOR
Published: 1987-03
Volume: 43
Issue: 1
Pages: 193
ISSN: 0006-341X (ISSN-L)
DOI: 10.2307/2531959
OpenAlex: W2090824711
Cited by: 341
References: 4
Citations by year: 2026: 6 · 2025: 9 · 2024: 10 · 2023: 8 · 2022: 7 · 2021: 11 · 2020: 8 · 2019: 10 · 2018: 13 · 2017: 5 · 2016: 13 · 2015: 9 · 2014: 20 · 2013: 8 · 2012: 25
FWCI: 4.23
Type: journal article
Language: en
Open access: closed
Locations: Biometrics (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA23415, CA-35446)
Topics: Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Physical Sciences › Mathematics › Statistics and Probability › Probability and Statistical Research
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
Keywords: group sequential tests, approximate optimality, clinical trial design, stopping boundaries
MeSH terms: Clinical Trials as Topic, Humans, Statistics as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Approximately Optimal One-Parameter Boundaries for Group Sequential Trials

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks